← Back to Patent Explorer
US4725677A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the preparation of oligonucleotides

Assignee: EMD Millipore Corp
•
Filing: 1984-08-10
•
Granted: 1988-02-16
•
Expires: 2004-08-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to a process for the preparation of oligonucleotides by the following steps: reaction of a nucleoside with a phosphine derivative, reaction of the nucleotide derivative thus obtained with a nucleoside bonded to a polymeric carrier, oxidation of the carrier-bound nucleoside-nucleotide thus obtained with formation of phosphotriester groups, blocking of free primary 5'-OH groups, elimination of a protective group from the terminal 5'-OH group, where appropriate single or multiple repetition of the abovementioned steps to introduce further nucleoside phosphate or oligonucleoside phosphate units, and cleavage of the nucleoside-carrier bond and, where appropriate, elimination of all protective groups present in the oligonucleoside phosphates. The phosphine derivative used is a compound of the general formula III ##STR1## in which X and L can react with OH groups of the sugar units in the oligonucleotides, and R 3 is a protective group which can be liberated by β-elimination.

Inventors

  • 👤 Hubert Koster
  • 👤 Nanda D. Sinha

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 13:26
CPC Classifications
C; C07; C07H; C07H21/00; C07F; C07F9/00; C07F9/02; C07F9/06; C07F9/22; C07F9/26; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 488 words
A process for the preparation of oligonucleotides of the general formula I in which B denotes a nucleoside base, R 1 denotes hydrogen, hydroxyl or hydroxyl which is protected by a removable protective group and n denotes an integer from 1 to 200, comprising the steps of (a) reacting a nucleoside of the general formula II ##STR14## in which R 1 as defined as above, and R 2 denotes a removable protective group and B' denotes the nucleoside base B protected by the protective groups which can be eliminated, with a phosphine derivative of the general formula III ##STR15## in which R 3 is a protective group which can be eliminated, and X and L are groups which react with hydroxyl groups in the sugar moieties of the nucleotides or nucleosides, in the presence of a base to thereby form a nucleotide phosphite (b) reacting the nucleotide phosphite obtained in step (a) and represented by the formula IV: ##STR16## in which B', R 1 , R 2 , R 3 and L are as defined above, with a nucleoside, of the general formula V, bound to a polymeric carrier ##STR17## in which B' and R 1 are as defined above and C denotes the polymeric carrier; (c) oxidizing the carrier-bound nucleoside-nucleotides obtained in step (b) and represented by the formula: ##STR18## in which B', R 1 , R 2 , R 3 and C are as defined above, with formation of phosphotriester groups, (d) blocking free primary 5'-OH groups, which have not been reacted in the reaction according to step (b), with permanent protective groups; (e) eliminating the protective group R 2 ; (f) optionally repeating steps (a) to (e) to introduce further nucleoside phosphate or oligonucleoside phosphate units; and (g) cleaving the nucleoside carrier bond and optionally eliminating the protective groups present in the oligonucleoside phosphates, which process comprises using in step (a) as the phosphine derivative of the general formula III a compound in which R 3 denotes a group of the formula VII ##STR19## in which the groups Y, which can be identical or different, represent hydrogen, methyl, and/or ethyl and Z represents an electron-attracting group, where, in the phosphine derivative of the formula III, X is chlorine, bromine, CN or SCN and L is CN or SCN, a secondary amino radical of the formula (VIII) --NR.sub.2.sup.4 where the groups R 4 are primary, secondary, or tertiary alkyl radicals having 1-10 carbon atoms, or together form a cycloalkyl radical having 5-7 carbon atoms, which can contain one or two nitrogen, oxygen, or sulfur atoms as hereoatoms, or are imidazole, triazole, tetrazole, 3-nitro-1,2,4-triazole, thiazole, pyrrole, benzotriazole, benzohydroxytriazole, imidazole substituted in the phenyl moiety, triazole substituted in the phenyl moiety, tetrazole substituted in the phenyl moiety, 3-nitro-1,2,4-triazole substituted in the phenyl moiety, thiazole substituted in the phenyl moiety, pyrrole substituted in the phenyl moiety, benzotriazole substituted in the phenyl moiety, or benzohydroxytrizole substituted in the phenyl moiety.
Claim 2
Dependent Claim 488 words
A process for the preparation of oligonucleotides of the general formula I in which B denotes a nucleoside base, R 1 denotes hydrogen, hydroxyl or hydroxyl which is protected by a removable protective group and n denotes an integer from 1 to 200, comprising the steps of (a) reacting a nucleoside of the general formula II ##STR14## in which R 1 as defined as above, and R 2 denotes a removable protective group and B' denotes the nucleoside base B protected by the protective groups which can be eliminated, with a phosphine derivative of the general formula III ##STR15## in which R 3 is a protective group which can be eliminated, and X and L are groups which react with hydroxyl groups in the sugar moieties of the nucleotides or nucleosides, in the presence of a base to thereby form a nucleotide phosphite (b) reacting the nucleotide phosphite obtained in step (a) and represented by the formula IV: ##STR16## in which B', R 1 , R 2 , R 3 and L are as defined above, with a nucleoside, of the general formula V, bound to a polymeric carrier ##STR17## in which B' and R 1 are as defined above and C denotes the polymeric carrier; (c) oxidizing the carrier-bound nucleoside-nucleotides obtained in step (b) and represented by the formula: ##STR18## in which B', R 1 , R 2 , R 3 and C are as defined above, with formation of phosphotriester groups, (d) blocking free primary 5'-OH groups, which have not been reacted in the reaction according to step (b), with permanent protective groups; (e) eliminating the protective group R 2 ; (f) optionally repeating steps (a) to (e) to introduce further nucleoside phosphate or oligonucleoside phosphate units; and (g) cleaving the nucleoside carrier bond and optionally eliminating the protective groups present in the oligonucleoside phosphates, which process comprises using in step (a) as the phosphine derivative of the general formula III a compound in which R 3 denotes a group of the formula VII ##STR19## in which the groups Y, which can be identical or different, represent hydrogen, methyl, and/or ethyl and Z represents an electron-attracting group, where, in the phosphine derivative of the formula III, X is chlorine, bromine, CN or SCN and L is CN or SCN, a secondary amino radical of the formula (VIII) --NR.sub.2.sup.4 where the groups R 4 are primary, secondary, or tertiary alkyl radicals having 1-10 carbon atoms, or together form a cycloalkyl radical having 5-7 carbon atoms, which can contain one or two nitrogen, oxygen, or sulfur atoms as hereoatoms, or are imidazole, triazole, tetrazole, 3-nitro-1,2,4-triazole, thiazole, pyrrole, benzotriazole, benzohydroxytriazole, imidazole substituted in the phenyl moiety, triazole substituted in the phenyl moiety, tetrazole substituted in the phenyl moiety, 3-nitro-1,2,4-triazole substituted in the phenyl moiety, thiazole substituted in the phenyl moiety, pyrrole substituted in the phenyl moiety, benzotriazole substituted in the phenyl moiety, or benzohydroxytrizole substituted in the phenyl moiety.
Claim 3
Dependent Claim 136 words
The process as claimed in claim 1, in which is used a phosphine derivative of the formula III in which X is chlorine or bromine, and L is a secondary amino radical of the formula (VIII) --NR.sub.2.sup.4 (VIII) where the groups R 4 are primary, secondary or tertiary alkyl radicals having 1-10 carbon atoms, or together form a cycloalkyl radical having 5-7 carbon atoms, which can contain one or two nitrogen, oxygen or sulfur atoms as heteroatoms, or are imidazole, triazole, tetrazole, 3-nitro-1,2,4-triazole, thiazole, pyrrole, benzotriazole, benzohydroxytriazole, imidazole substituted in the phenyl moiety, triazole substituted in the phenyl moiety, tetrazole substituted in the phenyl moiety, 3-nitro-1,2,4-triazole substituted in the phenyl moiety, thiazole substituted in the phenyl moiety, pyrrole substituted in the phenyl moiety, benzotriazole substituted in the phenyl moiety, or benzohydroxytrizole substituted in the phenyl moiety.
Claim 4
Dependent Claim 43 words
The process as claimed in claim 1 or 2, in which is used a phosphine derivative of the formula (III) in which X is chlorine, L is an N,N-dimethylamino, -diethylamino or -diisopropylamino group or N-morpholino group, and R 3 is a β-cyanoethyl group.
Claim 5
Independent Claim 210 words
A method of preparing oligonucleotides of the general formula: ##STR20## wherein B is a nucleoside base, R 1 is hydrogen, hydroxyl or hydroxyl which is protected by removable nucleoside protective groups, and n denotes an integer from 1 to 200, comprising the steps of: (a) reacting a nucleotide phosphite represented by the formula: ##STR21## wherein B' is a nucleoside base B protected by a base protective group which can be eliminated, R 1 is as defined above, R 2 is 4,4' dimethoxytrityl or 4,4',4" trimethoxytrityl; and L is N,N-dimethylamino, N,N-diethylamino, N,N-diisopropylamino, or N-morpholino, with a nucleoside bound to a polymeric carrier, of the general formula: ##STR22## wherein B' and R 1 are as defined above and C represents the polymeric carrier, to produce a carrier bound nucleoside-nucleotide of the formula: ##STR23## wherein B', R 1 , R 2 , R 3 and C are as defined above; (b) oxidizing the carrier bound nucleoside-nucleotide; (c) blocking free primary 5'-OH groups, which have not been reacted in the reaction of step (a), with permanent protective groups; (d) eliminating the protecting group R 2 ; (f) repeating steps (a) to (d) to introduce further nucleoside phosphate units; and (g) cleaving the nucleoside-carrier bond and optionally eliminating protective groups present in the oligonucleoside phosphates.
Claim 6
Independent Claim 210 words
A method of preparing oligonucleotides of the general formula: ##STR20## wherein B is a nucleoside base, R 1 is hydrogen, hydroxyl or hydroxyl which is protected by removable nucleoside protective groups, and n denotes an integer from 1 to 200, comprising the steps of: (a) reacting a nucleotide phosphite represented by the formula: ##STR21## wherein B' is a nucleoside base B protected by a base protective group which can be eliminated, R 1 is as defined above, R 2 is 4,4' dimethoxytrityl or 4,4',4" trimethoxytrityl; and L is N,N-dimethylamino, N,N-diethylamino, N,N-diisopropylamino, or N-morpholino, with a nucleoside bound to a polymeric carrier, of the general formula: ##STR22## wherein B' and R 1 are as defined above and C represents the polymeric carrier, to produce a carrier bound nucleoside-nucleotide of the formula: ##STR23## wherein B', R 1 , R 2 , R 3 and C are as defined above; (b) oxidizing the carrier bound nucleoside-nucleotide; (c) blocking free primary 5'-OH groups, which have not been reacted in the reaction of step (a), with permanent protective groups; (d) eliminating the protecting group R 2 ; (f) repeating steps (a) to (d) to introduce further nucleoside phosphate units; and (g) cleaving the nucleoside-carrier bond and optionally eliminating protective groups present in the oligonucleoside phosphates.
Claim 7
Independent Claim 87 words
A method of synthesizing oligonucleotides, comprising the steps of: (a) coupling a nucleoside β-cyanoethyl-protected phosphoramidite to a carrier-bound nucleoside to produce a carrier bound nucleoside-nucleotide having a phosphite triester linkage; (b) oxidizing the phosphite triester to form a phosphate triester; (c) optionally coupling additional nucleoside β-cyanoethyl-protected phosphoramidites to the carrier bound nucleoside-nucleotide and, after each coupling step, oxidizing the resulting phosphite triester to form a phosphate triester, to form a carrier bound polynucleotide; (d) removing the β-cyanoethyl protecting groups; and (e) removing the polynucleotide from the carrier.
Claim 8
Independent Claim 87 words
A method of synthesizing oligonucleotides, comprising the steps of: (a) coupling a nucleoside β-cyanoethyl-protected phosphoramidite to a carrier-bound nucleoside to produce a carrier bound nucleoside-nucleotide having a phosphite triester linkage; (b) oxidizing the phosphite triester to form a phosphate triester; (c) optionally coupling additional nucleoside β-cyanoethyl-protected phosphoramidites to the carrier bound nucleoside-nucleotide and, after each coupling step, oxidizing the resulting phosphite triester to form a phosphate triester, to form a carrier bound polynucleotide; (d) removing the β-cyanoethyl protecting groups; and (e) removing the polynucleotide from the carrier.
Claim 9
Dependent Claim 20 words
A method of claim 5, wherein the nucleoside β-cyanoethyl phosphoramidite is a nucleoside β-cyanoethyl N,N-dimethylphosphoramidite, N,N-diethylphosphoramidite, N,N-dipropylphosphoramidite or N,N-morpholino phosphoramidite.
Claim 10
Dependent Claim 12 words
A method of claim 6, wherein the carrier is controlled pore glass.
Claim 11
Dependent Claim 25 words
A method of claim 7, wherein the β-cyanoethyl protecting group is removed with simultaneous removal of the polynucleotide from the carrier, by concentrated aqueous ammonia.
Claim 12
Dependent Claim 38 words
In a method of polynucleotide synthesis, comprising sequentially coupling nucleotide phosphoramidites to produce a polynucleotide, wherein the phosphorus atoms of the nucleotide phosphoramidites are protected by methyl groups, the improvement wherein the phosphorus protecting group are cyanoethyl groups.
Claim 13
Dependent Claim 38 words
In a method of polynucleotide synthesis, comprising sequentially coupling nucleotide phosphoramidites to produce a polynucleotide, wherein the phosphorus atoms of the nucleotide phosphoramidites are protected by methyl groups, the improvement wherein the phosphorus protecting group are cyanoethyl groups.
Claim 14
Independent Claim 114 words
A method of synthesizing oligonucleotides, comprising the steps of: a. coupling a nucleoside β-cyanoethyl-protected phosphoramidite to a nucleoside, the nucleoside being bound to a polymeric carrier via an ester bond to produce a carrier-bound nucleoside-nucleotide having a phosphite triester linkage; b. oxidizing the phosphite triester to form a phosphate triester linkage; c. sequentially coupling additional nucleoside β-cyanoethyl protected phosphoramidite to the carrier-bound nucleoside-nucleotide, and after each coupling step, oxidizing the resulting phosphite triester linkage to a phosphate triester to produce a carrier-bound polynucleotide; d. treating the carrier bound polynucleotide with concentrated ammonia to remove the β-cyanoethyl phosphate protecting group and hydrolyzing the ester bond to the carrier to remove the polynucleotide from the carrier.
Claim 15
Independent Claim 114 words
A method of synthesizing oligonucleotides, comprising the steps of: a. coupling a nucleoside β-cyanoethyl-protected phosphoramidite to a nucleoside, the nucleoside being bound to a polymeric carrier via an ester bond to produce a carrier-bound nucleoside-nucleotide having a phosphite triester linkage; b. oxidizing the phosphite triester to form a phosphate triester linkage; c. sequentially coupling additional nucleoside β-cyanoethyl protected phosphoramidite to the carrier-bound nucleoside-nucleotide, and after each coupling step, oxidizing the resulting phosphite triester linkage to a phosphate triester to produce a carrier-bound polynucleotide; d. treating the carrier bound polynucleotide with concentrated ammonia to remove the β-cyanoethyl phosphate protecting group and hydrolyzing the ester bond to the carrier to remove the polynucleotide from the carrier.
Claim 16
Dependent Claim 20 words
A method of claim 10, wherein the nucleoside β-cyanoethyl phosphoramidite is a nucleoside β-cyanoethyl N,N-dimethylphosphoramidite, N,N-diethylphosphoramidite; N,N-dispropylphosphoramidite or N,N-morpholino phosphoramidite.
Claim 17
Dependent Claim 12 words
A method of claim 10, wherein the carrier is controlled pore glass.
Claim 18
Dependent Claim 190 words
A protected nucleotide having the formula: ##STR24## where, B' is a nucleoside base protected by a base protective group which can be eliminated; R 1 is H, OH, or a hydroxyl group which is protected by a removable nucleoside protective group; R 2 is a removable protective group; R 3 is ##STR25## L is CN, SCN, or NR 2 4 ; R 4 is a primary, secondary or tertiary alkyl radical having 1-10 carbon atoms, or R 2 4 is a cyloalkyl radical having 5-7 carbon atoms or a cycloalkyl radical having 5-7 atoms comprising atoms and one or two nitrogen, oxygen or sulfur atoms as heteroatoms; Y is H, CH 3 , or CH 2 CH 3 ; and Z is a halgen, CN, NO 2 , phenyl substituted in the o, o' or p positions with a halogen, CN or NO 2 radical, phenylthio, phenylsulfoxy, or phenylsulfonyl, where the phenyl radicals, may be substituted in the o, o' or p positions with a halgen, CN or NO 2 radical, or where the group ##STR26## may be replaced by CF 3 , CCl 3 , or CBr 3 .
Claim 19
Dependent Claim 190 words
A protected nucleotide having the formula: ##STR24## where, B' is a nucleoside base protected by a base protective group which can be eliminated; R 1 is H, OH, or a hydroxyl group which is protected by a removable nucleoside protective group; R 2 is a removable protective group; R 3 is ##STR25## L is CN, SCN, or NR 2 4 ; R 4 is a primary, secondary or tertiary alkyl radical having 1-10 carbon atoms, or R 2 4 is a cyloalkyl radical having 5-7 carbon atoms or a cycloalkyl radical having 5-7 atoms comprising atoms and one or two nitrogen, oxygen or sulfur atoms as heteroatoms; Y is H, CH 3 , or CH 2 CH 3 ; and Z is a halgen, CN, NO 2 , phenyl substituted in the o, o' or p positions with a halogen, CN or NO 2 radical, phenylthio, phenylsulfoxy, or phenylsulfonyl, where the phenyl radicals, may be substituted in the o, o' or p positions with a halgen, CN or NO 2 radical, or where the group ##STR26## may be replaced by CF 3 , CCl 3 , or CBr 3 .
Claim 20
Dependent Claim 11 words
A protected nucleotide as in claim 13, wherein Z is CN.
Claim 21
Dependent Claim 16 words
A protected nucleotide as in claim 14, wherein R 3 is CH 2 --CH 2 --CN.
Claim 22
Dependent Claim 14 words
A protected nucleotide as in claim 13, wherein R 2 is 4,4'-dimethoxytrityl or 4,4"-trimethoxytrityl.
Claim 23
Dependent Claim 63 words
A protected nucleotide having the formula: ##STR27## where, R 1 is H, OH, or a hydroxyl group which is protected by a removable nucleoside protective group; R 2 is 4,4'-dimethoxytrityl or 4,4',4"-trimethoxytrityl; B' is a nucleoside base protected by a base protective group which can be eliminated R 3 is CH 2 --CH 2 --CN; and L is N,N-dimethylamino, N,N-diethylamino, N,N-diisopropylamino or N-morpholino.
Claim 24
Dependent Claim 63 words
A protected nucleotide having the formula: ##STR27## where, R 1 is H, OH, or a hydroxyl group which is protected by a removable nucleoside protective group; R 2 is 4,4'-dimethoxytrityl or 4,4',4"-trimethoxytrityl; B' is a nucleoside base protected by a base protective group which can be eliminated R 3 is CH 2 --CH 2 --CN; and L is N,N-dimethylamino, N,N-diethylamino, N,N-diisopropylamino or N-morpholino.
Claim 25
Dependent Claim 88 words
A protected nucleotide having the formula: ##STR28## where, R 1 is H, OH, or a hydroxyl group which is protected by a protective group selected from the group consisting of trityl groups, acyl groups and silyl ether groups; R 2 is 4,4'-dimethoxytrityl or 4,4',4"-trimethoxytrityl; B' is a nucleoside base selected from the group consisting of adenine, guanine, cytosine, thymine, uracil and analogs thereof which are protected by acyl groups or Schiff bases; R 3 is CH 2 --CH 2 --CN; and L is N,N-dimethylamino, N,N-diethylamino, N,N-diisopropylamino, or N-morpholino.
Claim 26
Dependent Claim 88 words
A protected nucleotide having the formula: ##STR28## where, R 1 is H, OH, or a hydroxyl group which is protected by a protective group selected from the group consisting of trityl groups, acyl groups and silyl ether groups; R 2 is 4,4'-dimethoxytrityl or 4,4',4"-trimethoxytrityl; B' is a nucleoside base selected from the group consisting of adenine, guanine, cytosine, thymine, uracil and analogs thereof which are protected by acyl groups or Schiff bases; R 3 is CH 2 --CH 2 --CN; and L is N,N-dimethylamino, N,N-diethylamino, N,N-diisopropylamino, or N-morpholino.
Claim 27
Dependent Claim 40 words
A protected nucleotide of claim 18, wherein R 1 is H and B' is adenine, guanine, cytosine, thymine or uracil wherein the adenine or guanine is protected by a benzoyl group and the guanine is protected by an isobutyl group.

References Cited (Backward Citations)

US4310662A Cited
US4458066A Cited
US4500707A Cited
EP0040099A1 Cited
US4415732A Cited
EP0064796A2 Cited
US4419509A Cited
EP0090789A1 Cited
US4476301A Cited
US4605735A Cited
EP0131993A2 Cited
US4591614A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-02-15 1991-08-17 1992-02-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-02-15 1995-08-17 1996-02-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-02-15 1999-08-17 2000-02-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag